Biomarker Selection

DECADES OF EXPERIENCE

The selection of the appropriate biomarkers can significantly influence the success of a drug-development program. Our scientific and medical staff has more than 20 years of experience in biomarker development services for pharmaceutical and biotechnology drug-development programs. This experience can be leveraged to help select the markers that will yield data to enhance "go/no-go" decision effectiveness. Biomarker assays developed at Pathway Diagnostics have been used to assess target modulation, evaluate therapeutic benefit and stratify potential responders from non-responders.